✦ LIBER ✦

Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript

✍ Scribed by Barbara Pienkowska-Grela; Renata Woroniecka; Iwona Solarska; Kinga Kos; Anna Pastwińska; Lech Konopka; Miroslaw Majewski

Book ID: 113513088
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 198 KB
Volume: 174
Category: Article
ISSN: 0165-4608
DOI: 10.1016/j.cancergencyto.2006.11.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Different kinetic patterns of BCR-ABL tr

Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response

✍ Y. Z. QIN; Y. R. LIU; H. H. ZHU; J. L. LI; G. R. RUAN; Y. ZHANG; Q. JIANG; H. JI 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Major molecular response to imatinib in

Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

✍ Tchirkov, A; Couderc, J-L; Périssel, B; Goumy, C; Regnier, A; Uhrhammer, N; Verr 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB

Imatinib induces a cytogenetic response

Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts

✍ Lee, J-J; Kim, H-J; Kim, Y-J; Lee, S; Hwang, J-Y; Kim, Y-L; Kim, D-W 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Early prediction of molecular remission

Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse

✍ Yoo-Jin Kim; Dong-Wook Kim; Seok Lee; Chang-Ki Min; Hyun-Gyung Goh; Su-Hyun Kim; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A report of early cytogenetic response t

A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript

✍ Xiaoqing Li; Jing Yang; Xiangjun Chen; Jun Liu; Hongrui Li; Jine Zheng; Yanli He 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Isolated thrombocytosis as first sign of

Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib

✍ Massimo Breccia; Laura Cannella; Daniela Diverio; Paola Streponi; Mauro Nanni; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Since very few unusual BCR/ABL fusion transcripts in chronic myeloid leukemia have been reported, no clear evidence exists concerning their clinical and prognostic implications. We describe here a CML case with normal karyotype at standard cytogenetics and an atypical e6a2 BCR/ABL fusion transcript,